Sort
141,003 grants matching “cytokine”
NADPH Oxidases as Novel Targets for Cancer Therapy
$1,153,863James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
The Epidemiology of Home Allergens and Asthma
$1,153,847Diane R Gold · Brigham And Women'S Hospital · R01 · FY2006 · AI
Alternatively activated macrophages during type 2 immune responses
$1,153,680P'ng Loke · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Regulation of mucosal immune responses by helminth infections
$1,153,678P'ng Loke · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
AUTOIMUNE ARTHRITIS: GENETICS AND CELLULAR REGULATION
$1,153,665Tibor T Glant · Rush University Medical Center · P01 · FY2007 · AR
LJI Epitope Validation Center: Characterization of epitope-specific T cells responding to food, fungal and inner city allergens
$1,153,559Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2022 · AI
Stress and Addiction Neuroscience Unit
$1,153,510Leandro Vendruscolo · National Institute On Drug Abuse · ZIA · FY2023 · DA
RESEARCH CENTER FOR PHARMACOLOGY AND DRUG TOXICOLOGY
$1,153,281Vanderbilt University · P50 · FY2000 · GM
IMMUNE DYSREGULATION AND ALLERGIC ASTHMA
$1,153,205University Of New Mexico · P50 · FY2000 · HL
Human immune signatures of latent MTB infection, active disease and BCG vaccination
$1,153,021Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2015 · AI
Dermatology Consultation Service
$1,152,334Edward Cowen · Division Of Basic Sciences - Nci · ZID · FY2013 · CA
INITIATION AND PROPAGATION OF ASTHMATIC INFLAMMATION
$1,152,201Scripps Research Institute · P01 · FY2003 · AI
Strategies for Cancer Immunotherapy Clinical Trials
$1,151,937Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,151,937Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Immune Regulation in HCT
$1,151,709Robert S Negrin · Stanford University · P01 · FY2017 · CA
Immune Regulation in HCT
$1,151,707Robert S Negrin · Stanford University · P01 · FY2015 · CA
Immune Regulation in HCT
$1,151,707Robert S Negrin · Stanford University · P01 · FY2016 · CA
Development of a Novel Chemokine Receptor Antagonist as a Treatment for Opioid Use Disorder
$1,151,331Michael R Ruff · Creative Bio-Peptides, Inc. · R44 · FY2021 · DA
Genetics, Pathophysiology, and Treatment of Dominant Autoinflammatory Diseases
$1,151,045Daniel Kastner · National Human Genome Research Institute · ZIA · FY2011 · HG
Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases
$1,151,045Daniel Kastner · National Human Genome Research Institute · ZIA · FY2011 · HG
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,151,039Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Translational Research Center for CAM Therapy of Asthma
$1,151,035David B Peden · Univ Of North Carolina Chapel Hill · P01 · FY2008 · AT
Innate Determinants of Microbial Immunity
$1,150,939Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Neuroprotective And Neurorestorative Signaling Mechanisms
$1,150,803Mark P Mattson · National Institute On Aging · Z01 · FY2008 · AG
Development of Tissue Engineered Tregs as a Treatment for Acute Ischemic Stroke
$1,150,417Payam Zarin · Gentibio, Inc. · R44 · FY2025 · NS